ISRCTN10669312已完成3 期
Evaluating the Efficacy of a Novel Dermocosmetic Cream with 15% Azelaic Acid and Active Ingredients Complex, Presenting Soothing and Non-Irritant Properties, in Treating Papulopustular Rosacea: Results from a Randomized Trial
ISISPHARMA0 个研究点目标入组 69 人开始时间: 2023年1月16日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 69
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Male or female subjects aged 18 years and older
- •2. Clinical diagnosis of papulopustular rosacea (PPR) phenotype with at least 10 inflammatory lesions
排除标准
- •1. Pregnant or nursing woman
- •2. Subjects with rosacea of predominant phenotypes different from the phenotype of papules and pustules
- •3. Subjects with concomitant dermatoses that might interfere with the evaluation of lesions
- •4. Concomitant use of oral antibiotics and/or oral isotretinoin
- •5. Contraindications for the use of azelaic acid or metronidazole
研究者
相似试验
已完成
2 期
To evaluate the anti-aging efficacy of the products in healthy human volunteersCTRI/2018/12/016533ITC Life Sciences Technology Centre40
已完成
不适用
A study to see the dermatological efficacy of XXXXI on healthy skiJPRN-UMIN000019447Kao Corporation30
尚未招募
Unknown
Skin Lightening benefits studyCTRI/2023/04/051261ITC Life Sciences Technology Centre
尚未招募
Unknown
Skin pores benefits studyCTRI/2023/04/051262ITC Life Sciences Technology Centre
已完成
不适用
Anti-Ageing studyCTRI/2022/01/039627ITC Life Sciences Technology Centre151